Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2026-03-20

FDA Approved: CARBAMAZEPINE — Supplemental Application (Torrent Pharmaceuticals Limited)

View source ↗

Summary

FDA approved a supplemental application for carbamazepine from Torrent Pharmaceuticals Limited, resulting in labeling changes for the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbamazepine (Carbamazepine)

Snippet

SUPPL AP for CARBAMAZEPINE (CARBAMAZEPINE)